Preventive effects of jujube polysaccharides on fructose-induced insulin resistance and dyslipidemia in mice.

Yan Zhao,Xingbin Yang,Daoyuan Ren,Dongying Wang,Yang Xuan
DOI: https://doi.org/10.1039/c3fo60707k
IF: 6.3173
2014-01-01
Food & Function
Abstract:High fructose intake is associated with adverse metabolic syndromes. This study was designed to investigate whether the polysaccharides derived from Zizyphus jujube cv. Shaanbeitanzao (ZSP) could alleviate high fructose-induced insulin resistance and dystipidemia in mice. ZSP was identified by capillary zone electrophoresis as an acidic heteropolysaccharide with L-arabinose, D-galactose and D-galacturonic acid being the main component monosaccharides. Mice were provided with 20% high-fructose water and ZSP was administered intragastrically at doses of 0, 200 or 400 mg kg(-1) BW for 4 weeks. Fructose-treated mice showed hyperglycemia, hyperinsulinemia and dystipidemia with impaired insulin sensitivity (p < 0.05). Administration of ZSP at a dose of 400 mg kg(-1) BW significantly reduced the serum levels of glucose, insulin, TC, TG, LDL-C, and VLDL-C (p < 0.01). ZSP also markedly improved the HDL-C level, homeostasis model assessment for insulin resistance (HOMA-IR) and beta-cell function (HOMA-beta), and decreased the atherogenic index (AI) of the mice exposed to high-fructose water. Histopathological test with H&E and oil red O staining confirmed liver steatosis induced by a high-fructose diet and the hepatoprotective effect of ZSP. These findings indicate that the jujube polysaccharides may ameliorate insulin resistance and dyslipidemia in fructose-treated mice.
What problem does this paper attempt to address?